AGM
PRAX icon

Alpine Global Management’s Praxis Precision Medicines PRAX Stock Holding History

Alpine Global Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,328
Closed -$675K – 387
2024
Q2 		$675K Buy
+16,328
New +$772K 0.12% 145

Other funds holding PRAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alpine Global Management's PRAX Position: Q3 2024 in Review

Alpine Global Management sold out of Praxis Precision Medicines (PRAX) in Q3 2024, closing a stake of 16,328 shares — an estimated $675K sold.

Alpine Global Management first reported a position in PRAX in Q2 2024 and held it in 1 quarter. The position peaked at $675K in Q2 2024. 134 funds tracked by Wall St. Rank hold PRAX as of Q3 2024.

  • Alpine Global Management reported no remaining Praxis Precision Medicines position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 16,328 Praxis Precision Medicines shares in Q3 2024, an estimated $675K.
  • Alpine Global Management first reported a position in Praxis Precision Medicines in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Praxis Precision Medicines position peaked at $675K in Q2 2024.
  • 134 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.